36
17
Growth Score
-4 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4237679
Brussels-based specialty pharma company.
Acquired by 
Charterhouse Capital Partners
- Stephan Morgan: Non Executive DirectorPast Role: Armacell, Non Executive Director
- Jérémie Urbain: Shareholder / CEO
About the Company
SERB is a European specialty pharmaceutical group focused on prescription medicines which address rare and life-threatening diseases.
Following strategic acquisitions and targeted developments, SERB has succeeded in establishing a consistent drugs portfolio focused on niche specialty pharmaceuticals to maintain availability of life-saving
medicines and answer unmet medical needs.
Their commitment is to continue to offer essential drugs meeting Public Health needs.
